Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
Create a narrative
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
Novo Nordisk
BA
bactrian
Community Contributor
A Quality Compounder Marked Down on Overblown Fears
Novo Nordisk , a global leader in diabetes and obesity treatments, is trading at a deep discount to both its historical multiples and intrinsic value. The ADR is now priced at $47.05 , reflecting a normalized P/E ratio of just 13.4× , down from a five-year average closer to 25–30×.
View narrative
US$120.72
FV
57.7% undervalued
intrinsic discount
15.71%
Revenue growth p.a.
Set Fair Value
26
users have liked this narrative
7
users have commented on this narrative
61
users have followed this narrative
New
narrative
ASML Holding
IN
Investingwilly
Community Contributor
Why Now is the Time to buy ASML
What Does ASML Do? ASML Holding N.V. is a Dutch company and the world’s only supplier of extreme ultraviolet (EUV) lithography machines —a critical technology used to produce the world’s most advanced computer chips.
View narrative
US$1.00k
FV
28.0% undervalued
intrinsic discount
15.17%
Revenue growth p.a.
Set Fair Value
33
users have liked this narrative
6
users have commented on this narrative
89
users have followed this narrative
Updated
narrative
Wyndham Hotels & Resorts
ZW
Zwfis
Community Contributor
Wyndham Continues Global Expansion with 19% Ancillary Revenue Growth
WH is a company that I actually took interest in a couple of months ago when I happened to stay at one of their franchise hotels. I had to leave early in the morning at like 4 and when I went out to the parking lot I was astounded that in the little town I was was absolutely full.
View narrative
US$105.80
FV
20.6% undervalued
intrinsic discount
13.23%
Revenue growth p.a.
Set Fair Value
7
users have liked this narrative
2
users have commented on this narrative
14
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
TTEC Holdings
AN
AnalystConsensusTarget
Consensus Narrative from 1 Analyst
Financial And Healthcare Markets And AI Will Expand Opportunities
Key Takeaways TTEC's expansion into diverse markets and investment in AI and offshore delivery is expected to boost revenue and net margins. Strategic hiring and focus on recurring managed services are poised to enhance revenue stability and earnings growth.
View narrative
US$6.85
FV
50.1% undervalued
intrinsic discount
-4.33%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
about 22 hours ago
author updated this narrative
Inventiva
AN
AnalystConsensusTarget
Consensus Narrative from 4 Analysts
Phase III Trials Will Advance Lanifibranor For MASH Treatment
Key Takeaways Strategic focus on lanifibranor development, cutting other activities, and reducing workforce may improve net margins through operational efficiency. Key partnerships in Asia and financial strength ensure market penetration and support sustained investment, boosting future earnings potential.
View narrative
€6.20
FV
53.2% undervalued
intrinsic discount
66.11%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
6
users have followed this narrative
about 22 hours ago
author updated this narrative
FuelCell Energy
AN
AnalystConsensusTarget
Consensus Narrative from 6 Analysts
Cost Cuts And ExxonMobil Collaboration Will Shape Our Future
Key Takeaways Strategic partnerships and collaborations in energy and hydrogen sectors are boosting revenue growth and market expansion globally, particularly in Asia and the Americas. Cost-cutting and restructuring efforts aim to enhance profitability and improve financial performance through reduced operating expenses.
View narrative
US$7.38
FV
42.2% undervalued
intrinsic discount
33.74%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
47
users have followed this narrative
about 22 hours ago
author updated this narrative
TerrAscend
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
ERP Implementation And Ohio Expansion Will Improve Operational Efficiency
Key Takeaways Strategic expansions into new markets like Ohio and New Jersey are poised to enhance revenue and profitability through streamlined operations and vertical integration. Increased cultivation capacity and product diversification aim to boost market share by aligning with consumer preferences and capitalizing on legislative developments.
View narrative
CA$1.86
FV
60.2% undervalued
intrinsic discount
1.12%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
about 22 hours ago
author updated this narrative
PSQH
PSQ Holdings
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
FinTech Integration And Marketplace Expansion Will Drive Transformation
Key Takeaways The integration of Buy Now, Pay Later options and acquisition of Credova are poised to enhance revenue through expanded financial offerings. Cost optimization and strategic expansion initiatives, including the Marketplace and EveryLife brand, are expected to drive revenue, enhance cash flow, and improve profitability.
View narrative
US$6.00
FV
66.8% undervalued
intrinsic discount
62.15%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
7
users have followed this narrative
about 22 hours ago
author updated this narrative
Hansa Biopharma
AN
AnalystConsensusTarget
Consensus Narrative from 4 Analysts
Global Organ Transplantation Demand Will Expand Market Opportunity
Key Takeaways Expansion into new markets, improved reimbursement, and strong transplant demand are driving significant sales and margin growth for IDEFIRIX and other biologics. Advancing pipeline diversification and upcoming clinical readouts reduce single-product dependency, positioning for multi-asset growth and enhanced long-term earnings potential.
View narrative
SEK 75.50
FV
59.8% undervalued
intrinsic discount
89.78%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
5
users have followed this narrative
about 22 hours ago
author updated this narrative
American Outdoor Brands
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
BUBBA Smart Fish Scale And ClayCopter Will Expand Market Reach
Key Takeaways Innovative products and strategic retail partnerships are set to boost brand awareness, market reach, and revenue growth. The asset-light model and focus on subscription revenue support flexible operations and strong margins, enhancing profitability and growth.
View narrative
US$16.50
FV
44.2% undervalued
intrinsic discount
1.10%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
about 22 hours ago
author updated this narrative
WildBrain
AN
AnalystConsensusTarget
Consensus Narrative from 4 Analysts
Peanuts And Teletubbies Will Expand Global Consumer Markets
Key Takeaways Strategic focus on core franchises and global licensing, particularly Peanuts, aims to enhance revenue through expanded products and market penetration. Simplification of operations and focus on sustainable, high-cash-generative businesses support financial stability and earnings growth potential.
View narrative
CA$2.26
FV
23.5% undervalued
intrinsic discount
6.63%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
about 22 hours ago
author updated this narrative
Vuzix
AN
AnalystConsensusTarget
Consensus Narrative from 1 Analyst
CES 2025 And Quanta Investment Will Transform AR Manufacturing
Key Takeaways Strategic partnerships and product introductions position Vuzix for substantial revenue growth and market penetration, leveraging competitive pricing and industry interest. Collaborations and high-volume production could enhance margins and earnings, especially as defense and technology sectors expand.
View narrative
US$3.00
FV
31.2% undervalued
intrinsic discount
56.23%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
7
users have followed this narrative
about 22 hours ago
author updated this narrative
Value any company in seconds
Popular companies